Circular RNAs expression and function in myogenesis

Skeletal myogenesis is a well-characterized biological process driving the formation of the adult muscle tissue from mesodermal progenitors. The key molecular and cellular steps of such process can be replicated in vitro, by culturing muscle precursor cells called myoblasts, which can be induced to differentiate into mature myotubes. We characterized the role of a long non-coding RNA, linc-MD1, in regulating in vitro differentiation of murine myoblasts by acting as a molecular decoy for two microRNAs, miR-133 and miR-135, and we further dissected the regulation of linc-MD1 biosynthesis by the RNA binding protein HuR. Searching for new non-canonical RNA species involved in myogenesis, we directed our attention to circular RNAs (circRNAs). Circular RNAs are produced by the spliceosome via a particular reaction called back-splicing, which links a donor splice site to an upstream acceptor site, thereby generating a covalently closed RNA molecule. We performed high-throughput expression profiling of circRNAs in murine and human cells and studied the principles of their regulation during myogenesis. We then applied a high-content functional genomic screen of conserved circRNAs and found that these molecules are actively involved in the control of myoblasts differentiation. Among them, we further characterized circ-ZNF609 and found that it is able to control myoblast proliferation, providing the first example of a circular RNA involved in a relevant biological process. Moreover, sequence and biochemical analyses suggested that circ-ZNF609 might be translated in a functional protein, representing a possible molecular mechanism for circRNA function

An Unfulfilled Promise: Section 1557\u27s Failure to Effectively Confront Discrimination in Healthcare

When the Patient Protection and Affordable Care Act passed, it offered a broad promise to provide access to quality care on a nondiscriminatory basis. To achieve nondiscrimination, Congress included Section 1557, which integrated the nondiscrimination protections granted under Title VI of the Civil Rights Act of 1964, Title IX of the Education Amendments, Section 504, and the Age Discrimination Act. The language of the statute has proved that the section cannot achieve its broad promise. Covering only intentional discrimination and usually interpreted to divide the standard so that intersectional discrimination cannot be redressed, Section 1557 fails to address discrimination in a way that could effectively reduce health disparities and improve overall health outcomes. While it is possible to interpret the statute to provide for an intersectional claim, the limit to only intentional discrimination narrows the scope such that expanding Section 1557’s reach is necessary but not sufficient to improve the health of marginalized communities. As evidenced during the COVID-19 pandemic, implicit bias and disparate impact discrimination has a real impact in actual life and death healthcare decisions, for which the consequences must have an available remedy. Section 1557 opens the door to a broader approach but remains passive as a ‘nondiscrimination’ clause. Any further efforts to improve health outcomes and reduce health discrimination must take an active and intersectional ‘antidiscrimination’ approach

The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype

Substitutions, deletions and duplications in the dystrophin gene lead to either the severe Duchenne muscular dystrophy (DMD) or mild Becker muscular dystrophy depending on whether out-of-frame or in-frame transcripts are produced. We identified a DMD case (GSΔ44) where the correlation between genotype and phenotype is not respected, even if carrying a typical Duchenne mutation (exon 44 deletion) a Becker-like phenotype was observed. Here we report that in this patient, partial restoration of an in-frame transcript occurs by natural skipping of exon 45 and that this is due to the lack of Celf2a, a splicing factor that interacts with exon 45 in the dystrophin pre-mRNA. Several experiments are presented that demonstrate the central role of Celf2a in controlling exon 45 splicing; our data point to this factor as a potential target for the improvement of those DMD therapeutic treatments, which requires exon 45 skipping

The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA

Alterations in genetic programs required for terminal myeloid differentiation and aberrant proliferation characterize acute myeloid leukemia (AML) cells. Here, we identify the host transcript of miR-223, linc-223, as a novel functional long non-coding RNA (lncRNA) in AML. We show that from the primary nuclear transcript, the alternative production of miR-223 and linc-223 is finely regulated during monocytic differentiation. Moreover, linc-223 expression inhibits cell cycle progression and promotes monocytic differentiation of AML cells. We also demonstrate that endogenous linc-223 localizes in the cytoplasm and acts as a competing endogenous RNA for miR-125-5p, an oncogenic microRNA in leukemia. In particular, we show that linc-223 directly binds to miR-125-5p and that its knockdown increases the repressing activity of miR-125-5p resulting in the downregulation of its target interferon regulatory factor 4 (IRF4), which it was previously shown to inhibit the oncogenic activity of miR-125-5p in vivo. Furthermore, data from primary AML samples show significant downregulation of linc-223 in different AML subtypes. Therein, these findings indicate that the newly identified lncRNA linc-223 may have an important role in myeloid differentiation and leukemogenesis, at least in part, by cross-talking with IRF4 mRNA

C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia

Accumulating evidences indicate that different long non-coding RNAs (lncRNAs) might play a relevant role in tumorigenesis, with their expression and function already associated to cancer development and progression. CCAAT/enhancer-binding protein-α (CEBPA) is a critical regulator of myeloid differentiation whose inactivation contributes to the development of acute myeloid leukemia (AML). Mutations in C/EBPα occur in around 10% of AML cases, leading to the expression of a 30-kDa dominant negative isoform (C/EBPα-p30). In this study, we identified the oncogenic urothelial carcinoma associated 1 (UCA1) lncRNA as a novel target of the C/EBPα-p30. We show that wild-type C/EBPα and C/EBPα-p30 isoform can bind the UCA1 promoter but have opposite effects on UCA1 expression. While wild-type C/EBPα represses, C/EBPα-p30 can induce UCA1 transcription. Notably, we also show that UCA1 expression increases in cytogenetically normal AML cases carrying biallelic CEBPA mutations. Furthermore, we demonstrate that UCA1 sustains proliferation of AML cells by repressing the expression of the cell cycle regulator p27kip1. Thus, we identified, for the first time, an oncogenic lncRNA functioning in concert with the dominant negative isoform of C/EBPα in AML

Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma

Circular RNAs (circRNAs) represent a class of covalently closed RNAs, derived from non-canonical splicing events, which are expressed in all eukaryotes and often conserved among different species. We previously showed that the circRNA originating from the ZNF609 locus (circ-ZNF609) acts as a crucial regulator of human primary myoblast growth: indeed, the downregulation of the circRNA, and not of its linear counterpart, strongly reduced the proliferation rate of in vitro cultured myoblasts. To deepen our knowledge about circ-ZNF609 role in cell cycle regulation, we studied its expression and function in rhabdomyosarcoma (RMS), a pediatric skeletal muscle malignancy. We found that circ-ZNF609 is upregulated in biopsies from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS). Moreover, we discovered that in an ERMS-derived cell line circ-ZNF609 knock-down induced a specific block at the G1-S transition, a strong decrease of p-Akt protein level and an alteration of the pRb/Rb ratio. Regarding p-Akt, we were able to show that circ-ZNF609 acts by counteracting p-Akt proteasome-dependent degradation, thus working as a new regulator of cell proliferation-related pathways. As opposed to ERMS-derived cells, the circRNA depletion had no cell cycle effects in ARMS-derived cells. Since in these cells the p53 gene resulted downregulated, with a concomitant upregulation of its cell cycle-related target genes, we suggest that this could account for the lack of circ-ZNF609 effect in ARMS

Models, Metrics, and Investment: Mixing Venture Philanthropy and the Arts

Venture Philanthropy is an emerging trend in charity that reflects the successes of the booming venture capital industry. It translates the entrepreneurial philosophies focused on business models and scale into the non-profit sector. This study uses interviews with local arts leaders and critical thought to determine whether venture philanthropy has value to the arts and if the arts have value to venture philanthropists. Overall, this study found that the venture philanthropy criteria of measurable metrics, sustainable business models, and mission centric return on investments does not always apply to the arts. In the end, the study shows that venture philanthropy is not all that different than traditional funding models and its relevance to the arts may not be necessary.M.S., Arts Administration -- Drexel University, 201

Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis

Circular RNAs (circRNAs) constitute a family of transcripts with unique structures and still largely unknown functions. Their biogenesis, which proceeds via a back-splicing reaction, is fairly well characterized, whereas their role in the modulation of physiologically relevant processes is still unclear. Here we performed expression profiling of circRNAs during in vitro differentiation of murine and human myoblasts, and we identified conserved species regulated in myogenesis and altered in Duchenne muscular dystrophy. A high-content functional genomic screen allowed the study of their functional role in muscle differentiation. One of them, circ-ZNF609, resulted in specifically controlling myoblast proliferation. Circ-ZNF609 contains an open reading frame spanning from the start codon, in common with the linear transcript, and terminating at an in-frame STOP codon, created upon circularization. Circ-ZNF609 is associated with heavy polysomes, and it is translated into a protein in a splicing-dependent and cap-independent manner, providing an example of a protein-coding circRNA in eukaryotes

Dispersión de precios relativos: la inflación, importa? el caso argentino

Dispersión de precios relativos: la inflación, importa? el caso argentin